AmCyte Company

AmCyte develops encapsulated proliferated human islets for transplantation into patients with diabetes.

AmCyte develops encapsulated proliferated human islets for transplantation into patients with diabetes. The company specializes in adult stem cell research to treat diabetes with islet replacement therapy.
Technology: Regenerative medicine - cell therapy
Industry: Regenerative Medicine
Headquarters: Santa Monica
Founded Date: 1991
Employees Number: 11-50
Funding Status: M&A

Visit Website
Register and Claim Ownership